$SEM

Frist William H. sold (to issuer) $5.1M of SEM

Frist William H. sold (to issuer) 306,266 shares of SELECT MEDICAL HOLDINGS CORP (SEM) at $16.50 ($5.05M total) on 2026-06-30.

Original reporting
SEC EDGAR · Frist William H.
Published Jul 1, 2026, 6:25 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 1, 2026, 6:27 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$SEM
Neutral
medium confidence
Mentioned
$SEM
Relevance
6/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$SEMNeutralLow
01

Why it matters

The newest fact is the specific insider sale size, price ($16.50), and post-transaction holdings (0 shares). This can marginally influence sentiment but does not introduce new company fundamentals.

02

Market read

Traders may monitor for follow-on insider activity, but the disclosure alone is unlikely to drive a major repricing without accompanying fundamental news.

03

What to watch

No 10b5-1 plan is stated; traders may want to compare with prior Form 4 patterns and whether other insiders are selling/buying around the same period.

Relevance 6/10Novelty 5/10Timing: filed 2026-07-01 after-hours/late session (SEC Form 4)

Background

The article is an SEC Form 4 insider transaction disclosure for Select Medical Holdings (SEM).

Company-level read

Ticker impact

$SEMNeutralMedium confidence
Context

Select Medical Holdings director William H. Frist sold 306,266 shares to the issuer at $16.50 on 2026-06-30, per Form 4.

Expected impact

Low likelihood of a sustained price move; any impact is likely short-lived around the filing.

Evidence & confidence

The filing is primary-source and company-specific, but it is an insider sale (not a buy), and the text provides no new operational/regulatory catalyst—only transaction mechanics and size.

Market effects

Minimal; insider transaction does not change sector fundamentals for healthcare services.

None indicated.

None indicated.

Counterpoint

Because the sale is to the issuer (often tied to structured programs like buyback participation), it may be mechanical rather than a bearish view.

Key entities

  • SELECT MEDICAL HOLDINGS CORP

    Subject of the Form 4 insider transaction disclosure.

  • Frist William H.

    Director who sold 306,266 shares to the issuer on 2026-06-30.

Related articles

$QXOHighAI 9/10

Are KORE, SEM, BLD, QXO Obtaining Fair Deals for their Shareholders?

Halper Sadeh LLC said it is investigating potential securities-law or fiduciary-duty issues in deals involving KORE Group Holdings’ sale to Searchlight Capital Partners and Abry Partners for $9.25/share, Select Medical’s sale for $16.50/share, and TopBuild’s proposed acquisition by QXO. The firm also flagged QXO’s merger with TopBuild and said it may seek higher consideration or additional disclosures.

$QXOHighAI 9/10

Are KORE, SEM, BLD, QXO Obtaining Fair Deals for their Shareholders?

Halper Sadeh LLC said it is investigating potential securities-law violations and fiduciary-duty breaches involving KORE Group Holdings’ sale to Searchlight Capital Partners and Abry Partners for $9.25/share, Select Medical’s sale to a consortium led by its executives/directors for $16.50/share, and TopBuild’s proposed deal with QXO. TopBuild holders would choose $505 cash or 20.2 QXO shares per share.